CARDIFF ONCOLOGY, INC. Lessee, Operating Lease, Liability, to be Paid
CARDIFF ONCOLOGY, INC. (CRDF) had Lessee, Operating Lease, Liability, to be Paid of $866.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2026-02-24
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid $866.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $1.64M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $2.40M.
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid $2.77M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2025-12-31 | $866.00K 10-K · filed 2026-02-24 |
| 2024-12-31 | $1.64M 10-K · filed 2025-02-27 |
| 2023-12-31 | $2.40M 10-K · filed 2024-02-29 |
| 2023-06-30 | $2.77M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.95M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $3.14M 10-K · filed 2023-03-02 |
| 2022-09-30 | $3.32M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.50M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.68M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $3.75M 10-K · filed 2022-02-24 |
| 2021-09-30 | $3.97M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $415.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $659.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $898.88K 10-K · filed 2021-02-25 |
| 2020-09-30 | $1.14M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.37M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $1.61M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.84M 10-K · filed 2020-02-27 |
| 2019-09-30 | $2.07M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $2.30M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.53M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |